2008
DOI: 10.1016/j.ijpharm.2007.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan–prednisolone conjugate microspheres in rats with TNBS-induced colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
23
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 31 publications
1
23
0
Order By: Relevance
“…Among them, Eudragit ® L 100-55, a well known pharmaceutical excipient developed by the Röhm Company in Germany, has been widely used for the formulation of different oral dosage forms (e.g. tablet coating, tablet matrix, microspheres, nanoparticles) for colon-targeted drug delivery (Oosegi et al, 2008;Zakeri-Milani et al, 2009;Moustafine et al, 2006;Jelvehgari et al, 2010;Cetin et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Among them, Eudragit ® L 100-55, a well known pharmaceutical excipient developed by the Röhm Company in Germany, has been widely used for the formulation of different oral dosage forms (e.g. tablet coating, tablet matrix, microspheres, nanoparticles) for colon-targeted drug delivery (Oosegi et al, 2008;Zakeri-Milani et al, 2009;Moustafine et al, 2006;Jelvehgari et al, 2010;Cetin et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…26,[30][31][32] Orally delivered nanoparticles have been demonstrated to adhere to inflamed intestinal mucosa 33 and are effective in the treatment of experimental colitis. 34,35 Here we describe the fabrication, characterization, and in vitro testing of a biodegradable nanoparticulate drug delivery vehicle for retinoic acid composed of PLGA. We determined fabrication conditions and characterized the drug release profile and physical dimensions of our drug delivery vehicle.…”
Section: Development Of a Nanoparticulate Formulation Of Retinoic Acimentioning
confidence: 99%
“…Even at a moderate-dose repeated administration of drug for prolonged period causes many side effects such as diabetes, hypertension, Cushing syndrome and osteoporosis [14]. Earlier investigators performed numerous works to evaluate the drug release characteristics of prednisolone loaded in microspheres [15][16][17][18], but no one has considered the mathematical model design of the process that involves various process-variables for prednisolone. Only a few investigators have reported the effect of process variables on the characteristics of microspheres that have been prepared by the emulsion solvent evaporation method [5,[8][9][10].…”
Section: Introductionmentioning
confidence: 99%